Virupaksha, a beacon of innovation in pharmaceutical manufacturing, stands at the forefront of delivering high-purity Fluconazole, a critical medication for treating cryptococcal meningitis. With its state-of-the-art facilities that are both WHO-GMP and ISO 9001 certified, Virupaksha exemplifies excellence through stringent quality control measures and adherence to global standards.
This commitment is further underscored by its ISO 14001 certification, which highlights their dedication to sustainable practices, ensuring that every step of the manufacturing process not only meets rigorous health regulations but also respects environmental integrity. By prioritizing these certifications and focusing on the purity of their products, Virupaksha plays an essential role in combating life-threatening infections while maintaining an unwavering dedication to patient safety and care worldwide.
